Endometrioid Borderline Tumor Related to Ovarian Endometriosis

In: Investigations in Gynecology Research & Womens Health (IGRWH) · 2018 · vol. 1(4) · doi:10.31031/igrwh.2018.01.000520 · W2801934506
article OA: bronze CC0
AI-generated summary by gemini-2.5-flash-lite+body, 2026-08-03

This case report describes an endometrioid borderline tumor found with endometriosis in a 26-year-old woman, diagnosed via surgery and immunohistochemistry.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Full text 4,772 characters · extracted from oa-pdf · 3 sections · click to expand

Objective

We report a case of EBT with endometriosis in a 26-year-old woman. Case Report A 26-year-old female patient diagnosed with a left ovarian mass was referred to our institution for elective surgery. The patient presented with chronic pelvic pain (pain score 60-70 mm on a 100-mm visual analog scale) and dysmenorrhea since menarche at the age of 14 years, requiring the intake of nonsteroidal anti- inflammatory drugs and leading to asthenia. Ovarian mass was found 3 years earlier by ultrasonography. An analgesic therapy was prescribed. Gravida 1 and parity 0. Planning on getting pregnancy. She had family history of endometriosis and not oncological family history. On gynecological examination there was a palpable pelvic firm mass of about 10 cm in size in the left iliac region, solid-elastic texture with tenderness and displacement of the uterus to the right. Ultrasonography demonstrated a left ovarian cystic mass (12.0x8.7cm) with hyper-attenuated solid portions, thickened and with single loci of blood flow at CDI. The level of tumor markers HE4(63.72 pmol/L), CA 125(35.6U/mL), ROMA scores (23.97%) indicated a high malignant ovarian lesions risk in premenopausal women. On workup there was not revealed a prevalence of tumor. On laparoscopic surgical exploration the findings were left ovarian with adhesions, presented cystic mass measuring 11.5x10.0cm; uterosacral ligaments and broad ligaments of the uterus with multiple endometriotic nodules from 0.5 to 1.2cm. Laparoscopic left ovarian cystectomy, excision and ablation of endometriotic nodules, endometrial biopsy was performed. Postoperative was uncomplicated. Anna Protasova1*, Anna Tsypurdeeva1,2, Grigory Raskin1,3 and Nurana Bairamova1 1Department of Medicine, St. Petersburg University, St. Petersburg, Russia 2Ott Research Institute of Obstetrics, Gynecology and Reproductology, St. Petersburg, Russia 3Department of Pathology, Russian Scientific Center for Radiology and Surgical Technologies, St. Petersburg, Russia *Corresponding author: Anna Protasova, Department of Medicine, St. Petersburg University, St. Petersburg, Russia Submission: January 13, 2017; Published: January 23, 2018 Endometrioid Borderline Tumor Related to Ovarian Endometriosis Case Report Copyright © All rights are reserved by Anna Protasova. CRIMSONpublishers http://www.crimsonpublishers.com

Result

(a) (b) (c) (d) Figure 1: Endometrioid borderline tumor, H&E sections, 20x EE (a); expression of ER, 20x EE (b); Ki-67, 20x EE (c); BAF250a, 40x EE (d). ISSN: 2577-2015 How to cite this article: Anna P, Anna T, Grigory R, Nurana B. Endometrioid Borderline Tumor Related to Ovarian Endometriosis. Gynecol Res Women’s Health. 1(4). IGRWH.000520: 2018. DOI: 10.31031/IGRWH.2018.01.000520 74 Invest Gynecol Res Women’s HealthInvestigations in Gynecology Research & Womens Health Pathological findings presented both EBT with no invasion and endometriosis within this ovarian tumor. Microscopically, low papillary lesions with squamous morules were detected as well as focal atrophic glandular linings with polymorphic cells. Nuclear stratification was noted, but no invasive growth was apparent. Typical endometriosis lesions were present. Immunohistochemical studies demonstrated positive for estrogen receptor (ER), progesterone receptor (PR), Epithelial Membrane Antigen (EMA), negative for p53, alpha-inhibin, Wilms tumor gene (WT1). Ki- 67 labeling index was 8%. Loss BAF250a (encoded by ARID1A) expression in EBT and endometriotic tissue did not observe (Figures 1a-1d). Final diagnosis was ovarian endometrioid borderline tumor stage IA. The patient had been taking Dienogest 2mg once daily treatment. The follow-up every three months within 36 months showed no evidence of disease recurrence. To date, this woman aged 29 years has a regular menstruation, no pelvic pain and does not plan a pregnancy in near future.

Conclusion

Therefore, this report implies association between endometriosis and EBT . Histological and IHC establish a diagnosis EBT and optimize surgical treatment in reproductive aged women, as well as preserve fertility.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-pdf

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK